T. Rowe Price Health Sciences Fund I Class
THISX
NASDAQ
| Weiss Ratings | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | T. Rowe Price | |||
| Manager/Tenure (Years) | Ziad Bakri (9), Jason(Jay) Nogueira (0) | |||
| Website | http://www.troweprice.com | |||
| Fund Information | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | T. Rowe Price Health Sciences Fund I Class | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Mar 23, 2016 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 500,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.19% | |||
| Dividend | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.79% | |||
| Asset Allocation | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.79% | |||
| Stock | 90.23% | |||
| U.S. Stock | 78.69% | |||
| Non-U.S. Stock | 11.54% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.15% | |||
| Other Net | 8.83% | |||
| Price History | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.04% | |||
| 30-Day Total Return | 1.90% | |||
| 60-Day Total Return | 1.93% | |||
| 90-Day Total Return | -6.70% | |||
| Year to Date Total Return | -4.93% | |||
| 1-Year Total Return | -9.34% | |||
| 2-Year Total Return | -1.09% | |||
| 3-Year Total Return | 12.25% | |||
| 5-Year Total Return | 20.83% | |||
| Price | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $75.78 | |||
| 1-Month Low NAV | $73.75 | |||
| 1-Month High NAV | $77.73 | |||
| 52-Week Low NAV | $72.14 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $102.82 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.57 | |||
| Standard Deviation | 14.20 | |||
| Balance Sheet | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 11.05B | |||
| Operating Ratios | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.67% | |||
| Turnover Ratio | 52.40% | |||
| Performance | THISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.51% | |||
| Last Bear Market Total Return | -9.85% | |||